Cutaneous Lymphocyte Antigen Is a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma

被引：7

作者：

Peru, Sara ^{[1
]}

Prochazkova-Carlotti, Martina ^{[1
]}

Cherrier, Floriane ^{[1
]}

Velazquez, Joanne ^{[1
]}

Richard, Elodie ^{[1
]}

Idrissi, Yamina ^{[1
]}

Cappellen, David ^{[1
,2
,3
]}

Azzi-Martin, Lamia ^{[1
,4
]}

Pham-Ledard, Anne ^{[1
,5
]}

Beylot-Barry, Marie ^{[1
,5
]}

Merlio, Jean-Philippe ^{[1
,2
,3
]}

Poglio, Sandrine ^{[1
]}

机构：

[1] Univ Bordeaux, BRIC BoRdeaux Inst onCol, UMR1312, INSERM, F-33000 Bordeaux, France

[2] Bordeaux Univ Hosp, Tumor Bank, Pessac, France

[3] Bordeaux Univ Hosp, Tumor Biol Lab, Pessac, France

[4] Bordeaux Univ, UFR Sci Med, Bordeaux, France

[5] Bordeaux Univ Hosp, Dermatol Dept, Bordeaux, France

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2022年 / 142卷 / 12期

关键词：

TREATMENT-OF-CANCER; SEZARY-SYNDROME; MYCOSIS-FUNGOIDES; HECA-452; ADHESION; RECEPTOR; CLASSIFICATION; ACTIVATION; XENOGRAFT; SELECTIN;

D O I：

10.1016/j.jid.2022.06.016

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Cutaneous T-cell lymphoma (CTCL) such as Se ' zary syndrome or mycosis fungoides corresponds to an abnormal infiltration of T lymphocytes in the skin. CTCL cells have a heterogeneous phenotype and express cell adhesion molecules such as cutaneous lymphocyte antigen (CLA) supporting skin homing. The use of a mAb (HECA-452) against CLA significantly decreased transendothelial migration and survival of CTCL cells from patient samples and My-La cell line. The decrease of CLA expression by inhibition of its maturation enzyme, ST3 0-galactoside a-2,3-sialyltransferase 4, also impaired CTCL cell migration, proliferation, and survival. We confirmed in vivo that treatment with anti-CLA mAb decreased the tumorigenicity as well as dissemination of CTCL cells in different tissues compared with the control group. Our findings provide evidence of the involvement of CLA in CTCL cell migration and survival, supporting that CLA inhibition could represent an actionable therapy in patients with CTCL.

引用

页码：3243 / +

页数：20

共 34 条

[1] Intrahepatic Xenograft of Cutaneous T-Cell Lymphoma Cell Lines A Useful Model for Rapid Biological and Therapeutic Evaluation [J].

Andrique, Laetitia ;

Poglio, Sandrine ;

Prochazkova-Carlotti, Martina ;

Kadin, Marshall Edward ;

Giese, Alban ;

Idrissi, Yamina ;

Beylot-Barry, Marie ;

Merlio, Jean-Philippe ;

Chevret, Edith .

AMERICAN JOURNAL OF PATHOLOGY, 2016, 186 (07) :1775-1785

[2] NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity [J].

Armstrong, Florence ;

de la Grange, Philippe Brunet ;

Gerby, Bastien ;

Rouyez, Marie-Christine ;

Calvo, Julien ;

Fontenay, Michaela ;

Boissel, Nicolas ;

Dombret, Herve ;

Baruchel, Andre ;

Landman-Parker, Judith ;

Romeo, Paul-Henri ;

Ballerini, Paola ;

Pflumio, Francoise .

BLOOD, 2009, 113 (08) :1730-1740

[3] THE CUTANEOUS LYMPHOCYTE ANTIGEN IS A SKIN LYMPHOCYTE HOMING RECEPTOR FOR THE VASCULAR LECTIN ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULE-1 [J].

BERG, EL ;

YOSHINO, T ;

ROTT, LS ;

ROBINSON, MK ;

WARNOCK, RA ;

KISHIMOTO, TK ;

PICKER, LJ ;

BUTCHER, EC .

JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1461-1466

[4] Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in Sezary cells [J].

Brouwer, Isabella J. ;

Out-Luiting, Jacoba J. ;

Vermeer, Maarten H. ;

Tensen, Cornelis P. .

BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2020, 24

[5] Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors [J].

Campbell, James J. ;

Clark, Rachael A. ;

Watanabe, Rei ;

Kupper, Thomas S. .

BLOOD, 2010, 116 (05) :767-771

[6] Humanization of an Anti-CCR4 Antibody That Kills Cutaneous T-Cell Lymphoma Cells and Abrogates Suppression by T-Regulatory Cells [J].

Chang, De-Kuan ;

Sui, Jianhua ;

Geng, Shusheng ;

Muvaffak, Asli ;

Bai, Mei ;

Fuhlbrigge, Robert C. ;

Lo, Agnes ;

Yammanuru, Anuradha ;

Hubbard, Luke ;

Sheehan, Jared ;

Campbell, James J. ;

Zhu, Quan ;

Kupper, Thomas S. ;

Marasco, Wayne A. .

MOLECULAR CANCER THERAPEUTICS, 2012, 11 (11) :2451-2461

[7] The vast majority of CLA+ T cells are resident in normal skin [J].

Clark, Rachael A. ;

Chong, Benjamin ;

Mirchandani, Nina ;

Brinster, Nooshin K. ;

Yamanaka, Kei-ichi ;

Dowgiert, Rebecca K. ;

Kupper, Thomas S. .

JOURNAL OF IMMUNOLOGY, 2006, 176 (07) :4431-4439

[8] Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance [J].

Cristofoletti, Cristina ;

Bresin, Antonella ;

Picozza, Mario ;

Picchio, Maria Cristina ;

Monzo, Francesca ;

Citterich, Mauro Helmer ;

Passarelli, Francesca ;

Frezzolini, Alessandra ;

Scala, Enrico ;

Monopoli, Alessandro ;

Cantonetti, Maria ;

Benucci, Roberto ;

D'Atri, Stefania ;

Caprini, Elisabetta ;

Russo, Giandomenico ;

Narducci, Maria Grazia .

LEUKEMIA, 2019, 33 (05) :1231-1242

[9] Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas [J].

de Masson, Adele ;

Beylot-Barry, Marie ;

Bouaziz, Jean-David ;

de Latour, Regis Peffault ;

Aubin, Francois ;

Garciaz, Sylvain ;

d'Incan, Michel ;

Dereure, Olivier ;

Dalle, Stephane ;

Dompmartin, Anne ;

Suarez, Felipe ;

Battistella, Maxime ;

Vignon-Pennamen, Marie-Dominique ;

Rivet, Jacqueline ;

Adamski, Henri ;

Brice, Pauline ;

Francois, Sylvie ;

Lissandre, S Verine ;

Turlure, Pascal ;

Wierzbicka-Hainaut, Ewa ;

Brissot, Eolia ;

Dulery, Remy ;

Servais, Sophie ;

Ravinet, Aurelie ;

Tabrizi, Reza ;

Ingen-Housz-Oro, Saskia ;

Joly, Pascal ;

Socie, Gerard ;

Bagot, Martine .

HAEMATOLOGICA, 2014, 99 (03) :527-534

[10]

DEBOER OJ, 1994, IMMUNOLOGY, V81, P359

← 1 2 3 4 →